RhumbLine Advisers’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

RhumbLine Advisers’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81	Hold	33	–	–	﹤0.01%	4056
2025 Q4	$131	Hold	33	–	–	﹤0.01%	4086
2025 Q3	$124	Sell	33 -300	-90%	-$1.02K	﹤0.01%	4082
2025 Q2	$805	Sell	333 -28	-8%	-$38	﹤0.01%	4052
2025 Q1	$297	Sell	361 -1,006	-74%	-$955	﹤0.01%	4077
2024 Q4	$1.16K	Hold	1,367	–	–	﹤0.01%	4069
2024 Q3	$1.69K	Hold	1,367	–	–	﹤0.01%	4068
2024 Q2	$2.28K	Sell	1,367 -4	-0.3%	-$7	﹤0.01%	4174
2024 Q1	$2.55K	Hold	1,371	–	–	﹤0.01%	4067
2023 Q4	$2.6K	Sell	1,371 -2,405	-64%	-$3.59K	﹤0.01%	4069
2023 Q3	$4.98K	Hold	3,776	–	–	﹤0.01%	3983
2023 Q2	$11.3K	Buy	+3,776	New	+$12.1K	﹤0.01%	3915

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RhumbLine Advisers's NBP Position: Q1 2026 in Review

RhumbLine Advisers held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q1 2026 at 33 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

RhumbLine Advisers first reported a position in NBP in Q2 2023 and has held it in 12 quarters since. The position peaked at $11.3K in Q2 2023. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

RhumbLine Advisers held 33 shares of NovaBridge Biosciences American Depositary Shares worth $81 as of Q1 2026.
RhumbLine Advisers left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #4056 holding.
RhumbLine Advisers first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2023 and has held it in 12 quarters since.
RhumbLine Advisers's NovaBridge Biosciences American Depositary Shares position peaked at $11.3K in Q2 2023.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.